Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1900 and is headquartered in Abbott Park, IL.
Frequently Asked Questions
What is market cap of Abbott Laboratories?
The market cap of Abbott Laboratories is $170.41B
What is the 52 week high for Abbott Laboratories?
The 52 week high for Abbott Laboratories is $124.36.
What is the 52 week low for Abbott Laboratories?
The 52 week low for Abbott Laboratories is $93.25.
What is Abbott Laboratories stock price today?
Abbott Laboratories' stock price today is $98.05.
What is the pe ratio of Abbott Laboratories?
The PE ratio of Abbott Laboratories is 25.07.
What is the price to book ratio of Abbott Laboratories?
The price to book ratio of Abbott Laboratories is 4.6446.
What is Abbott Laboratories's EBITDA?
Abbott Laboratories's EBITDA is 11629.
What is the 50-day moving average of Abbott Laboratories?
The 50-day moving average of Abbott Laboratories is 105.3728.